News

Take this opportunity to book a free hybrid speed consulting session with Pharmetheus’ consultants in connection to WCoP 2022! Sign up here Pharmetheus is looking forward to World Conference on Pharmacometrics in Cape Town! 

A recent publication describes a model-based population PK and exposure-response analysis for Astegolimab in Patients with severe asthma. This analysis supports the rationale for  Astegolimab dosing as the highest dose tested in

The Pharmetheus team just completed its review and training on the final FDA Population Pharmacokinetics guidance, confirming that our approaches and reports are fully compliant.  If you haven’t done so already, check

Pharmetheus takes an active interest in several initiatives aiming to develop software solutions to support the MIDD applications of tomorrow. Our support for Pumas AI represents one of these initiatives: Pumas-AI, Inc.

Check out this new release of the OSP CYP3A4-DDI qualification report, where Pharmetheus in partnership with Boehringer Ingelheim contributed by adding a perpetrator contributed by adding a perpetrator (fluconazole) with 3 victims

For Pharmetheus, our corporate social responsibility (CSR) ambitions are to become an even more sustainable and responsible company. Like all initiatives within Pharmetheus, our CSR strategy stems from our vision and core

Our engagement in PBPK-QSP takes many forms! We’ve recently kicked off three new research projects, about i) an infrastructure for streamlining processes of PBPK projects, ii) a framework for evaluating the performance

Do you have experience working as Project Coordinator? Do you want to be part of a fantastic team in an expanding international organization? Pharmetheus keeps moving forward and is looking to grow

Pharmetheus is a proud sponsor, workshop organizer, poster author, and attendee delegation to WCoP in March. Hats off to the hosts for fantastic organization as illustrated in this video.